Amneal (NASDAQ: AMRX) EVP gifts 152K shares to family trust

Rhea-AI Filing Summary

Amneal Pharmaceuticals, Inc. (AMRX) reported that Executive Vice President Andrew S. Boyer made a bona fide gift of 152,426 shares of Class A Common Stock on 2026-08-21. The shares were gifted to a trust for the benefit of certain family members, where Boyer does not serve as trustee. Following this transfer, Boyer’s reported direct holdings are 273,646 shares of Class A Common Stock.

Insider Trade Summary

Net Seller: 152,426 shares

Net Sell 1 txn

Insider BOYER ANDREW S

Role Executive Vice President

Type	Security	Shares	Price	Value
Gift	Class A Common Stock F1	152,426	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 273,646 shares (Direct)

Footnotes (1)

1. F1. Represents a gift to trust for the benefit of certain family members whereby reporting person does not serve as trustee.

Key Figures

Shares gifted: 152,426 shares of Class A Common Stock Per-share transaction price: $0.00 per share Shares owned after transaction: 273,646 shares of Class A Common Stock +1 more

4 metrics

Shares gifted 152,426 shares of Class A Common Stock Bona fide gift on 2026-08-21 by Executive Vice President Andrew S. Boyer

Per-share transaction price $0.00 per share Reported price for the bona fide gift of 152,426 shares

Shares owned after transaction 273,646 shares of Class A Common Stock Direct holdings reported for Andrew S. Boyer following the gift

Gift share count (summary) 152,426 shares Total gift shares in this Form 4 transaction summary

Key Terms

bona fide gift, trust, trustee

3 terms

bona fide gift financial

"transaction_code_description": "Bona fide gift"

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

trust financial

"Represents a gift to trust for the benefit of certain family members"

A trust is a legal setup in which one party (the trustee) holds and manages assets—like cash, stocks or property—on behalf of other people (beneficiaries) according to instructions from the person who created it (the grantor). Think of it as a locked box with a keyholder who must follow written rules; for investors it matters because trusts influence who controls and benefits from assets, affect taxes and succession, and can change how quickly or transparently shares are bought, sold or voted.

trustee financial

"for the benefit of certain family members whereby reporting person does not serve as trustee"

A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

FAQ

What insider transaction did AMRX report for Andrew S. Boyer?

Amneal Pharmaceuticals, Inc. (AMRX) reported that Executive Vice President Andrew S. Boyer made a bona fide gift of 152,426 shares of Class A Common Stock on 2026-08-21, transferring them to a trust for the benefit of certain family members.

How many AMRX shares did Andrew S. Boyer transfer in this Form 4 filing?

Andrew S. Boyer transferred 152,426 shares of Amneal Pharmaceuticals Class A Common Stock as a bona fide gift. The transaction carried a reported per-share price of $0.00, consistent with its classification as a gift.

What are Andrew S. Boyer’s AMRX holdings after this reported gift?

After the reported gift transaction, Andrew S. Boyer’s remaining direct holdings in Amneal Pharmaceuticals Class A Common Stock are 273,646 shares, as stated in the Form 4 filing.

Who benefits from the gifted AMRX shares reported by Andrew S. Boyer?

The 152,426 gifted shares of Amneal Pharmaceuticals Class A Common Stock were transferred to a trust for the benefit of certain family members. The filing notes that Boyer does not serve as trustee of this trust.

Does Andrew S. Boyer retain control over the gifted AMRX shares?

The filing notes that the 152,426 shares were gifted to a trust for family members and that Andrew S. Boyer does not serve as trustee, indicating that control over those gifted shares resides with the trust’s trustee, not Boyer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/25/2026 - 04:42 PM Accepted by SEC EDGAR 08/25/2026 - 04:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOYER ANDREW S

(Last) (First) (Middle)

C/O AMNEAL PHARMACEUTICALS, INC.

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Amneal Pharmaceuticals, Inc. [ AMRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/21/2026		G(1)		152,426	D	$0	273,646	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a gift to trust for the benefit of certain family members whereby reporting person does not serve as trustee.

Remarks:

	/s/ Denis Butkovic, Attorney-in-Fact	08/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)